Getein Biotech

Getein Biotech EBIT per Share

The EBIT per Share of Getein Biotech (603387.SS) as of Oct 12, 2026 is 0.55 CNY. In the previous year, EBIT per Share was 0.50 CNY — a change of 9.60% (higher).

EBIT per Share

0.55CNY

YoY

9.60%

Last updated:

EBIT per Share of Getein Biotech is 2025 0.55 CNY. EBIT per Share of Getein Biotech was 2024 0.50 CNY. It decreases by 9.60% higher compared to the previous year.

The Getein Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
0.54 CNY
Jan 1, 2019
0.78 CNY
Jan 1, 2020
0.76 CNY
Jan 1, 2021
0.86 CNY
Jan 1, 2022
1.12 CNY
Jan 1, 2023
0.60 CNY
Jan 1, 2024
0.50 CNY
Jan 1, 2025
0.55 CNY
The Getein Biotech EBIT per Share history
YEAREBIT per ShareYoY
0.55CNY+9.60%
0.50CNY-17.19%
0.60CNY-46.01%
1.12CNY+30.31%
0.86CNY+13.18%
0.76CNY-2.21%
0.78CNY+43.82%
0.54CNY+23.03%
0.44CNY+8.53%
0.40CNY+35.54%
0.30CNY+72.71%
0.17CNY+18.21%
0.15CNY+216.00%
0.05CNY—
Access this data via the Eulerpool API
Get Free API Key

Getein Biotech Stock analysis

What does Getein Biotech do? Getein Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Getein Biotech stock

EBIT per Share of Getein Biotech is 0.55 CNY in 2025.

EBIT per Share of Getein Biotech changed from 0.50 CNY to 0.55 CNY, representing a 9.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Getein Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Getein Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Getein Biotech